B-Raf inhibitor 1

Alias: B-Raf Inhibitor 1; B-Raf-Inhibitor 1; B-Raf-Inhibitor-1
Cat No.:V3442 Purity: ≥98%
B-Raf inhibitor 1 is a novel, potent and selectiveRafkinase inhibitor withKis of 1 nM, 1 nM, and 0.3 nM for B-RafWT, B-RafV600E, and C-Raf, respectively.
B-Raf inhibitor 1 Chemical Structure CAS No.: 1093100-40-3
Product category: Raf
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
250mg
500mg
Other Sizes

Other Forms of B-Raf inhibitor 1:

  • B-Raf inhibitor 1 dihydrochloride
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

B-Raf inhibitor 1 is a novel, potent and selective Raf kinase inhibitor, with Kis of 1 nM, 1 nM, and 0.3 nM for B-RafWT, B-RafV600E, and C-Raf, respectively. One of the growth signal transduction protein kinases in the Raf kinase family is B-Raf. This protein controls the MAP kinase/ERKs signaling pathway, which controls cell proliferation, differentiation, and secretion.

Biological Activity I Assay Protocols (From Reference)
Targets
B-Raf (Ki = 1 nM); B-RafV600E (Ki = 1 nM); c-Raf (Ki = 0.3 nM)
ln Vitro
Raf inhibitor 1 (Compound 13) inhibits the proliferation of A375 and HCT-116 with IC50 values of 0.31 and 0.72 M, respectively. The ATP pocket on B-Raf is partially filled by Phe595 and Gly596 from the DFG motif when Raf inhibitor 1 (Compound 13) binds to it and stabilizes it in a DFG-out, inactive conformation. Additionally, Raf inhibitor 1 (Compound 13) inhibits wild type B-Raf cell lines at low micromolar concentrations, which may be the result of pan-Raf inhibition, including Raf dimers, or alternatively off-target kinase activities[1].
References

[1]. Conformation-specific effects of Raf kinase inhibitors. J Med Chem. 2012 Sep 13;55(17):7332-41.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C26H19CLN8
Molecular Weight
478.9357
Exact Mass
478.14
Elemental Analysis
C, 65.20; H, 4.00; Cl, 7.40; N, 23.40
CAS #
1093100-40-3
Related CAS #
Raf inhibitor 1 dihydrochloride;1191385-19-9
Appearance
Solid powder
SMILES
CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC=C(C=C3)Cl)NC4=C(C=CC=N4)C5=C6C(=NC=N5)N=CN6
InChi Key
KKVYYGGCHJGEFJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H19ClN8/c1-15-4-9-19-18(10-12-29-24(19)34-17-7-5-16(27)6-8-17)21(15)35-25-20(3-2-11-28-25)22-23-26(32-13-30-22)33-14-31-23/h2-14H,1H3,(H,28,35)(H,29,34)(H,30,31,32,33)
Chemical Name
1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine
Synonyms
B-Raf Inhibitor 1; B-Raf-Inhibitor 1; B-Raf-Inhibitor-1
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 50~96 mg/mL (104.4~200.4 mM)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0879 mL 10.4397 mL 20.8794 mL
5 mM 0.4176 mL 2.0879 mL 4.1759 mL
10 mM 0.2088 mL 1.0440 mL 2.0879 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02967692 Active
Recruiting
Biological: Spartalizumab
Other: Placebo
Melanoma Novartis Pharmaceuticals February 17, 2017 Phase 3
NCT03026517 Active
Recruiting
Drug: Dabrafenib
Drug: Trametinib
Melanoma Memorial Sloan Kettering
Cancer Center
January 2017 Phase 1
NCT03410875 Active
Recruiting
Drug: Vemurafenib
Drug: Obinutuzumab
Leukemia
Hairy Cell Leukemia
Memorial Sloan Kettering
Cancer Center
February 9, 2018 Phase 2
NCT04655157 Active
Recruiting
Drug: encorafenib
Drug: nivolumab
Melanoma Jason J. Luke, MD May 28, 2021 Phase 1
Phase 2
NCT03101254 Active
Recruiting
Drug: LY3022855
Drug: Vemurafenib
Melanoma Dana-Farber Cancer Institute June 6, 2017 Phase 1
Phase 2
Contact Us Back to top